ANTHONY GREGG LAPOINTE - 02 Jun 2021 Form 4 Insider Report for CATABASIS PHARMACEUTICALS INC (ATXS)

Role: Director
Signature: /s/ Ben Harshbarger, as attorney-in-fact for Gregg Anthony LaPointe
Issuer symbol: ATXS
Transactions as of: 02 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 02 Jun 2021, 19:13:54 UTC
Previous filing: 21 May 2021
Next filing: 24 Sep 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATXS	Stock Option (right to buy)	Award	$0	+100,000		$0.000000	100,000	02 Jun 2021	Common Stock	100,000	$2.04	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on June 2, 2021 and is schedule to vest in equal annual installments over a three-year period from the date of grant, subject to the director's continued service.